Overview / Abstract: |
Target Audience This activity is intended for primary care providers, internal-medicine specialists, pediatricians, pulmonologists, cardiologists, endocrinologists, gastroenterologists, hepatologists, neurologists, neuromuscular specialists, infectious-disease specialists, obstetricians/gynecologists, rheumatologists, dermatologists, hematologists, oncologists, neonatologists, genetic counselors, social workers, psychologists, nurse practitioners, physician assistants, nurses, and pharmacists Learning Objectives Upon completion of this activity, participants should be better able to: Summarize the key steps of development programs for gene therapies, identifying how and why some programs may differ from others Alessandra Biffi, MD Kevin Flanigan, MD Kimberly Goodspeed, MD Stephan A. Grupp, MD, PhD John Kessler, MD Julie A. Parsons, MD Perry B. Shieh, MD, PhD, FAAN |
Expiration |
Apr 22, 2022 |
Discipline(s) |
Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME, Psychology CE |
Format |
Online |
Credits / Hours |
1.0 AMA PRA Category 1 Credit(s)™ |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Faculty Alessandra Biffi, MD Kevin Flanigan, MD Kimberly Goodspeed, MD Stephan A. Grupp, MD, PhD John Kessler, MD Julie A. Parsons, MD Perry B. Shieh, MD, PhD, FAAN |
Sponsors / Supporters / Grant Providers |
Astellas Gene Therapies; AVROBIO, Inc.; Biogen; CRISPR Therapeutics, Inc.; Helixmith Co., Ltd; Orchard Therapeutics; REGENXBIO Inc.; and uniQure, Inc. |
Keywords / Search Terms |
Relias LLC Relias LLC., FreeCME., Cell and Gene‐Based Therapies Free CE CME |